Three Growth ETFs Down This Month, One Looks Like a Buy
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesThree growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...
The VIX nears the 30 threshold as geopolitical tensions and energy prices spike risk. Markets brace for a choppier we...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
As the 10-year Treasury crosses 4.6%, ETF dynamics for VOO and IVV face renewed scrutiny. Markets weigh rate paths, i...
Warby Parker lit up the market with a notable stock move this week. This article breaks down the drivers behind the s...
Strategy Just Made Smallest Bitcoin Purchase In 2026, buying 535 BTC for about $43 million, signals a potential shift...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Citi lifts Coca-Cola's price target to $91 from $90, citing the World Cup marketing push as a key catalyst. The move ...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
AI-driven data center expansion is accelerating, intensifying power demands and highlighting nuclear energy as a pote...
Modine Manufacturing faced a pivotal Q4 print as investors eye margin recovery and cash flow. The stock surged ahead ...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...